Heart Failure Survival

Cross-source consensus on Heart Failure Survival from 1 sources and 6 claims.

1 sources · 6 claims

Risks & contraindications

In the survival cohort, survival was 88.41% at 30 days, 81.18% at 90 days, and 70.05% at 1 year. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study
Five-year survival in the 2014-2018 cohort was 36.38%. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study
Nine-year survival among patients enrolled in 2014 was 17.66%. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study
Survival after index heart failure hospitalisation declined progressively with longer follow-up. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study
Survival was worse in older age groups at every observed follow-up point. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study
The 2019-2022 cohort had better 30-day, 90-day, and 1-year survival than the 2014-2018 cohort, except among patients under 50 years. — Changes in the epidemiology of heart failure in the decade 2014–2023: insights from the AQUORE retrospective cohort study